Ken Fisher Fisher Asset Management
AUM
$293B
1-Year Est. Return
28.33%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Fund
S&P 500
1 Year Est. Return
+28.33%
AUM
$293B
AUM Growth
+$16.7B
(+6%)
Holding
1,126
Top Buys
| 1 | +$4.56B | |
| 2 | +$441M | |
| 3 | +$281M | |
| 4 |
NVIDIA
NVDA
|
+$278M |
| 5 |
Microsoft
MSFT
|
+$230M |
Top Sells
| 1 | +$2.05B | |
| 2 | +$1.6B | |
| 3 | +$284M | |
| 4 |
Itaú Unibanco
ITUB
|
+$247M |
| 5 |
Intuit
INTU
|
+$160M |
Sector Composition
| 1 | Technology | 25.35% |
| 2 | Financials | 19.13% |
| 3 | Healthcare | 9.52% |
| 4 | Industrials | 9.41% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
UBS Group
UBS
$114B
| $2.97B | 1.01% |
64,107,264
+2,938,827
|
|
||
27
Bank of America
BAC
$335B
| $2.96B | 1.01% |
53,783,821
+1,105,833
|
|
||
28
Sony
SONY
$128B
| $2.79B | 0.95% |
108,981,588
+4,337,062
|
|
||
29
Costco
COST
$447B
| $2.74B | 0.93% |
3,176,286
+31,045
|
|
||
30
Visa
V
$591B
| $2.63B | 0.9% |
7,485,132
+125,909
|
|
||
31
Merck
MRK
$286B
| $2.62B | 0.89% |
24,873,327
+805,201
|
|
||
32
Mastercard
MA
$444B
| $2.49B | 0.85% |
4,355,805
+47,405
|
|
||
33
BP
BP
$109B
| $2.31B | 0.79% |
66,431,924
+948,692
|
|
||
34
Barclays
BCS
$70.5B
| $2.28B | 0.78% |
89,750,069
+3,722,757
|
|
||
35
Charles Schwab
SCHW
$163B
| $2.18B | 0.74% |
21,818,514
+171,926
|
|
||
36
Intuitive Surgical
ISRG
$168B
| $2.14B | 0.73% |
3,784,970
-104,469
|
|
||
37
Johnson Controls International
JCI
$79.7B
| $2.06B | 0.7% |
17,239,953
+280,704
|
|
||
38
Shell
SHEL
$252B
| $1.99B | 0.68% |
27,142,785
+332,839
|
|
||
39
AstraZeneca
AZN
$295B
| $1.99B | 0.68% |
21,601,433
+438,709
|
|
||
40
Blackrock
BLK
$144B
| $1.95B | 0.67% |
1,824,359
-77,808
|
|
||
41
Netflix
NFLX
$402B
| $1.92B | 0.66% |
20,490,399
+151,649
|
|
||
42
Johnson & Johnson
JNJ
$582B
| $1.83B | 0.63% |
8,866,207
+419,799
|
|
||
43
Oracle
ORCL
$446B
| $1.82B | 0.62% |
9,314,177
+269,158
|
|
||
44
UnitedHealth
UNH
$256B
| $1.75B | 0.6% |
5,293,622
+41,173
|
|
||
45
Cummins
CMI
$74B
| $1.74B | 0.59% |
3,410,723
+43,722
|
|
||
46
Capital One
COF
$112B
| $1.68B | 0.57% |
6,937,362
-358,865
|
|
||
47
GSK
GSK
$107B
| $1.63B | 0.56% |
33,195,985
+968,370
|
|
||
48
Thermo Fisher Scientific
TMO
$173B
| $1.62B | 0.55% |
2,792,421
+71,320
|
|
||
49
Rio Tinto
RIO
$143B
| $1.57B | 0.54% |
19,642,744
+522,576
|
|
||
50
Procter & Gamble
PG
$350B
| $1.56B | 0.53% |
10,908,367
-100,087
|
|